Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN111484459A details a Pd-catalyzed asymmetric hydrogenation method offering high enantioselectivity and green atom economy for pharmaceutical intermediates.
Novel preparation of Venetoclax impurities I and III ensures high purity and supply chain stability for global pharmaceutical manufacturers.
Patent CN110551059B reveals a metal-free, visible-light driven synthesis of 3-sulfonylspiro[4,5]trienones using DABSO, offering significant cost reduction and supply chain stability.
Novel Bacillus megaterium strain enables high-purity R-4-chloro-3-hydroxybutyrate production with reduced costs and environmental impact.
Patent CN1113885C details a novel aluminum halide method for deprotecting beta-lactams, offering high yields and recyclable protecting groups for cost-effective API manufacturing.
Patent CN1613860A reveals a mild synthesis route for cephem onium salts. Discover cost-effective manufacturing and high-purity cefpirazole intermediate supply solutions.
Patent CN1134446C reveals a high-yield deprotection method for cefdinir intermediates using perhalic acid, offering significant cost reduction in antibiotic manufacturing.
Patent CN1126754C reveals a novel one-pot synthesis for 3-cephem antibiotics, offering significant cost reduction and improved stability for API manufacturing supply chains.
Patent CN104277050B details a novel crystallization method for Moxidectin. This process enhances purity and reduces purification complexity for supply chains.
Discover the novel bio-chemical synthesis of prednisolone acetate via patent CN112375114A. Achieve high purity and yield with cost-effective industrial scaling.
Novel patent CN105481724B details efficient leonurine synthesis. Offers supply chain stability and cost reduction in pharmaceutical manufacturing for global buyers.
Patent CN118600444A enables green electrochemical synthesis. Reduces cost and improves supply chain reliability for phosphorimide derivatives manufacturing processes.
Patent CN104193620A reveals hydrazine-activated oxygen synthesis for high-purity intermediates. Delivers cost reduction and scalable supply chain reliability.
Patent CN117658864B details a high-yield route for sacubitril intermediates offering supply chain stability and cost reduction for pharmaceutical manufacturing.
Novel method improves yield and purity for cefoxitin intermediates. Reduces side reactions and enhances supply chain stability for antibiotic manufacturing.
Patent CN1446795A details a high-yield synthesis of N-salicyloyl-8-aminocaprylic acid sodium. This report analyzes the mild acylation route for cost-effective pharmaceutical intermediate manufacturing.
Patent CN110358804B reveals high-purity enzymatic resolution for dolutegravir synthesis, offering scalable biocatalysis solutions for reliable pharmaceutical intermediate suppliers.
Patent CN105820079A discloses a stable urea derivative with efficient synthesis. This route offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN107311953A details a mild synthesis of antitumor dihydroisoxazole licochalcone A. This report analyzes cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN110777125B details a novel Y127W mutant enzyme for high-concentration synthesis of chiral piperidine intermediates, offering significant cost reduction in API manufacturing.